öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÃçÑÓΡ
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º30

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º Éñ¾­Ó°ÏñѧÕï¶ÏÓëÁÙ´²Ó¦ÓÃ
Ñо¿ÁìÓò£º Éñ¾­Ó°ÏñѧÕï¶ÏÓëÁÙ´²Ó¦Óà [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**-3086
µç×ÓÓʼþ£ºywmiao716@163.com


¸öÈ˼òÊö :
ÃçÑÓΡ£¬ÄУ¬Ò½Ñ§²©Ê¿£¬½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦£»·ÅÉä¿Æ¸±Ö÷ÈΡ£ 1994Äê±ÏÒµÓÚÖйúÒ½¿Æ´óѧӰÏñϵ£¬´ÓÊÂÓ°ÏñÕï¶ÏÓëÑо¿¹¤×÷ÖÁ½ñ£¬Éó¤ÓÚÉñ¾­ÏµÍ³¡¢Îå¹Ù¼°¾±²¿¼²²¡Ó°ÏñÕï¶Ï¡£2006-2009Ä꣬ÔÚÖ°¾Í¶ÁÌì½òÒ½¿Æ´óѧӰÏñҽѧ²©Ê¿Ñ§Î»¡£ÒµÎñÄÜÁ¦½ÏÇ¿£¬²¢¾ßÓнÏÇ¿µÄ¿ÆÑÐÒâʶºÍ´´ÐÂÄÜÁ¦£¬Ö÷³Ö²¢²ÎÓë¶àÏî¿ÆÑÐÏîÄ¿£¬°üÀ¨4Ïî¹ú¼Ò×ÔÈ»»ù½ðÏîÄ¿ºÍ1Ïî´óÁ¬ÊпƼ¼¾Ö»ù½ðÏîÄ¿¡£ÏÖÈδóÁ¬ÊÐҽѧ»á·ÅÉäѧ·Ö»áίԱ¡¢·ÅÉäÕï¶ÏÖÊ¿ØÖÐÐĸ±Ö÷ÈÎίԱ£»µ£ÈΡ¶ÖйúÉñ¾­ÔÙÉúÑо¿£¨Ó¢Îİ棩¡·¡¢¡¶Öйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´¡·¡¢¡¶MRIÔÓÖ¾¡·µÈ¶à¸öÔÓÖ¾±àί¡¢Éó¸åר¼Ò¡£

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¨**£©: ¶à·¢ÐÔÓ²»¯Ö¢Ìú³Á»ý¼°Ñݱä»úÖƵĶàģ̬´Å¹²Õñ½á¹¹ºÍ¹¦ÄܳÉÏñ×ÝÏòÑо¿£¬ÏîÄ¿Ö÷³ÖÈË£¬2012Äê1ÔÂ-2015Äê12Ô£¬58ÍòÔª
´ú±íÎÄÕÂ
(1) Li M, Hu J, Miao Y*, et al. In Vivo Measurement of Oxygenation Changes after Stroke Using Susceptibility Weighted Imaging Filtered Phase Data. Plos One, 2013, 8£¨5£©£ºe63013.
(2) Miao YW, Juh¨¢sz C, Wu JL, et al. Clinical correlates of white matter blood flow perfusion changes in Sturge-Weber syndrome: A dynamic MR perfusion -weighted imaging study. AJNR Am J Neuroradiol£¬2011£¬32£¨8£©£º1281-1285.
(3) ÁõÌúÀû£¬ÕžºÎÄ£¬Ì·ÑÞ÷£¬Î齨ÁÖ£¬ÃçÑÓΡ£ª.´ÅÃô¸Ð¼ÓȨ³ÉÏñ¼¼ÊõÆÀ¹ÀÕý³£ÈËȺÄÔ¾²ÂöѪÏàλֵ. ÖйúҽѧӰÏñ¼¼Êõ£¬2013£¬29£¨2£©£º197-201
£¨4£©Ö£³Ì³Ì£¬²ÌÕ׳Ï£¬·ë½à£¬Å£ÌïÁ¦£¬ÃçÑÓΡ£ª.Sturge-Weber×ÛºÏÕ÷ñ²ðï·¢×÷ÓëÄÔѪÁ÷¶¯Á¦Ñ§µÄÏà¹ØÐÔÑо¿. ´Å¹²Õñ³ÉÏñ£¬2013,4£¨2£©£º93-98
£¨5£©ÃçÑÓΡ£¬ÎºÇ¿£¬º«î£µÈ.¶à·¢ÐÔÓ²»¯°ß¿éÖÜΧÕý³£±íÏÖ°×ÖʵĴÅÃô¸Ð¼ÓȨ³ÉÏñ¼°¶¯Ì¬´ÅÃô¸ÐÔöÇ¿¹à×¢³ÉÏñ. ´Å¹²Õñ³ÉÏñ£¬2011,2£¨4£©£º273-277